Revance Therapeutics

December 02, 2020

US FDA approval tracker: November

October 30, 2020

Go or no go? Big decisions loom for Bristol and Sanofi

The FDA will have a busy November, with decisions due for Bristol, Sanofi and Y-mabs, among others.

October 14, 2020

Revance irons out the wrinkles with its longer-acting Botox

June 26, 2019

Botox and the value of never-ending profits

Abbvie’s bid for Allergan shows that the Botox franchise is impenetrable. The market agrees.

March 02, 2018

Snippet roundup: Mylan lines up Botox biosimilar but Vernalis sinks

December 06, 2017

Revance data erase frowns for now

November 03, 2017

Upcoming events – Revance’s phase III challenge and round two for Axovant

April 03, 2014

Biotech floats hint at a narrowing gap between perception and reality

April 01, 2014

Biotech’s record-breaking quarter shines spotlight on sustainability

February 10, 2014

IPO boom sees biotechs going where the money is

February 05, 2014

Soon-to-be-publics top VC rounds of 2013 while seed funding shows an uptick

Load More